Dr. Pimstone, MD, PhD, FRCPC is a founder, Director, and President and Chief Executive Officer at Xenon Pharmaceuticals Inc., one of Canada’s leading privately owned biotechnology companies. Xenon is engaged in discovering and developing novel pharmaceuticals targeting genes and proteins that underlie human diseases.

He received his MD from the University of Cape Town and his PhD through the University of Amsterdam. He is an internal medicine specialist (FRCPC) with an interest in cardiovascular disease.

Dr. Pimstone has served as a consultant physician at the St. Paul’s Hospital Lipid Clinic in Vancouver. He is currently the Chairman of the Providence Healthcare Research Institute, and he serves as a Director on the Board of Life Sciences British Columbia.

In 2005 he received the Business in Vancouver Top 40 under 40 Award and in 2004 the Globe & Mail’s Canadian Top 40 Under 40 Award. Dr. Pimstone is the author of numerous peer-reviewed publications and is also a regular guest speaker at international scientific meetings and healthcare conferences.